---
title: "Astrana Health, Inc. (ASTH.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/ASTH.US.md"
symbol: "ASTH.US"
name: "Astrana Health, Inc."
industry: "Health Care Services"
---

# Astrana Health, Inc. (ASTH.US)

| Item | Detail |
|------|--------|
| Industry | Health Care Services |
| Location | US Market |
| Website | [www.astranahealth.com](https://www.astranahealth.com) |

## Company Profile

Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, sp...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-25T04:30:15.000Z

**Overall: B (0.36)**

**Industry**: Health Care Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 18 / 86 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 68.17% |  |
| Net Profit YoY | -84.73% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 1.24 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 963.99M |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 2.90B |  |


**Multi Score**: B

#### Profit Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 1.29% | D |
| Profit Margin | 0.33% | C |
| Gross Margin | 10.17% | E |

#### Growth Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 68.17% | A |
| Net Profit YoY | -84.73% | E |
| Total Assets YoY | 74.05% | A |
| Net Assets YoY | 9.39% | B |

#### Cash Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 30370.68% | A |
| OCF YoY | 68.17% | A |

#### Operating Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 1.64 | A |

#### Debt Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 75.20% | E |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Astrana Health, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "1.29%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "0.33%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "10.17%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "B",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "68.17%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "-84.73%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "74.05%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "9.39%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "A",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "30370.68%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "68.17%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "A",
      "indicators": [
        {
          "name": "Turnover",
          "value": "1.64",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "E",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "75.20%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | TalkSpace (US.TALK) | C | B | A | A | A | A |
| 02 | Cigna (US.CI) | B | B | A | D | B | B |
| 03 | BrightSpring Health Services - Unit (US.BTSGU) | C | A | A | D | A | B |
| 04 | Labcorp (US.LH) | B | C | B | C | B | B |
| 05 | Quest Diagnostics (US.DGX) | B | B | B | C | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 101.08 | 26/79 | 115.86 | 57.28 | 35.37 |
| PB | 1.24 | 17/79 | 2.09 | 1.78 | 1.51 |
| PS (TTM) | 0.33 | 16/79 | 0.68 | 0.57 | 0.42 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-09T05:00:00.000Z

Total Analysts: **11**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 8 | 73% |
| Overweight | 1 | 9% |
| Hold | 2 | 18% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 19.95 |
| Highest Target | 50.00 |
| Lowest Target | 26.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/ASTH.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/ASTH.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/ASTH.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.